Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by AstraZeneca Pharmaceuticals (Ireland) DAC .
Filed returns
18
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Jan–Apr 2026 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Invitation to the opening of AstraZeneca’s new Active Pharmaceutical Ingredient manufacturing facility & Bilateral Meeting (Public policy or programme) | 14 | On lobbying.ie |
| Jan–Apr 2026 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Meetings and Follow up - World Economic Forum Annual Meeting 2026 (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2025 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Meeting request - World Economic Forum Annual Meeting 2026 (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2025 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Sharing a Proposal for an Early Access Programme for Innovative Oncology Medicines Budget 2026 (Matters involving public funds) | 27 | On lobbying.ie |
| May–Aug 2025 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Alexion - Cork office launch event (Public policy or programme) | 12 | On lobbying.ie |
| Jan–Apr 2025 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Discuss impact of proposed tariffs on the pharmaceutical sector in Ireland (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2025 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Meeting request - World Economic Forum Annual Meeting 2025 (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2024 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Alexion - Engagement regarding Ireland’s life sciences operating environment (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2024 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Inequity of access to new cancer medicines for cancer patients (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2024 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Meeting to discuss AstraZeneca's footprint in Ireland and relevant policy issues (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2023 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Engagement regarding funding for new medicines (Matters involving public funds) | 5 | On lobbying.ie |
| Jan–Apr 2023 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Update on AstraZeneca operations in Ireland (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2022 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Outreach in support of a lung cancer screening programme in Ireland (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2022 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Update on AstraZeneca operations in Ireland (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2022 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | High Tech medicines policy in Ireland (Legislation) | 5 | On lobbying.ie |
| May–Aug 2022 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Update on AstraZeneca operations in Ireland (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2022 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Briefing on AstraZeneca's Covid-19 treatments (Public policy or programme) | 5 | On lobbying.ie |
| Jan–Apr 2022 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Briefing on AstraZeneca's Covid-19 treatments (Public policy or programme) | 6 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 18 | 100.0% |